ICD-10 Coding for ESBL-producing E. coli Infection(A41.5, A41.51, A41.51B)
Learn how to accurately code ESBL-producing E. coli infections using ICD-10 codes, including Z16.12 for resistance and U93 as a flag code.
Complete code families applicable to ESBL-producing E. coli Infection
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z16.12 | Resistance to extended-spectrum beta-lactamase (ESBL) | Use when ESBL-producing E. coli is confirmed via lab tests. |
|
| A41.51 | Sepsis due to Escherichia coli | Use when sepsis is confirmed to be caused by E. coli. |
|
| N39.0 | Urinary tract infection, site not specified | Use for UTIs confirmed to be caused by E. coli. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutESBL-producing E. coli Infection
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting ESBL-producing E. coli Infection.
Omitting U93 flag code
Impact
Clinical: Incomplete documentation of resistance, Regulatory: Non-compliance with coding standards, Financial: Potential claim denials
Mitigation
Review coding guidelines, Ensure U93 is included when applicable
Incorrect sequencing of codes
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate healthcare data reporting.
Mitigation
Ensure infection site or sepsis codes are primary, followed by Z16.12 and U93.
Antimicrobial resistance coding
Impact
Incorrect coding of resistance can lead to audit findings.
Mitigation
Ensure lab confirmation and correct code sequencing.